US2010254904A1PendingUtilityA1

Novel therapeutic delivery systems

Assignee: BRISTOL MYERS SQUIBB MEDICAL IPriority: Nov 30, 1993Filed: Aug 1, 2006Published: Oct 7, 2010
Est. expiryNov 30, 2013(expired)· nominal 20-yr term from priority
A61K 9/127A61K 49/227A61K 9/1278A61P 43/00A61K 41/0028A61K 9/1277A61K 47/6925A61K 41/0052A61M 5/3145A61K 49/223
69
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Targeted therapeutic delivery systems comprising gas- or gaseous precursor-filled lipid microspheres comprising a therapeutic are described. Methods for employing such microspheres in therapeutic delivery applications are also provided. Targeted therapeutic delivery systems comprising gas- or gaseous precursor-filled liposomes having a drug encapsulated therein are preferred. Methods of and apparatus for preparing such liposomes and methods for employing such liposomes in therapeutic delivery applications are also disclosed.

Claims

exact text as granted — not AI-modified
1 - 40 . (canceled) 
     
     
         41 . A method for preparing a targeted therapeutic delivery system comprising temperature activated gaseous precursor-filled liposomes, the method comprising shaking an aqueous solution, comprising a lipid and a therapeutic compound, in the presence of a gaseous precursor, at a temperature below the gel to liquid crystalline phase transition temperature of the lipid, and at the activation temperature of the gaseous precursor or below the activation temperature. 
     
     
         42 . The method of  claim 41 , wherein the method is carried out at the activation temperature of the gaseous precursor. 
     
     
         43 . The method of  claim 41 , wherein the shaking comprises vortexing. 
     
     
         44 . The method of  claim 41 , further comprising filtering and heat sterilizing the aqueous lipid solution. 
     
     
         45 . The method of  claim 41 , further comprising extruding the gaseous precursor-filled liposomes through at least one filter of a selected pore size. 
     
     
         46 . The method of  claim 45 , wherein the pore size is about 10 μm or smaller. 
     
     
         47 . The method of  claim 41 , further comprising hydrating a dried lipid to form an aqueous solution comprising a lipid. 
     
     
         48 . A method for preparing a targeted therapeutic delivery system comprising gaseous precursor-filled liposomes, the method comprising:
 (a) shaking an aqueous solution, comprising a lipid, in the presence of a gaseous precursor, at a temperature below the gel to liquid crystalline phase transition temperature of the lipid, to form gaseous precursor-filled liposomes; and   (b) adding to the liposomes a therapeutic compound.   
     
     
         49 . The method of  claim 48 , wherein the method is carried out at the activation temperature of the gaseous precursor. 
     
     
         50 . The method of  claim 48 , wherein the shaking vortexing. 
     
     
         51 . The method of  claim 48 , further comprising filtering and heat sterilizing the aqueous lipid solution. 
     
     
         52 . The method of  claim 48 , further comprising extruding the liposomes through at least one filter of a selected pore size. 
     
     
         53 . The method of  claim 48 , wherein the pore size is about 10 μm or smaller. 
     
     
         54 . The method of  claim 48 , further comprising hydrating a dried lipid to form an aqueous solution comprising a lipid. 
     
     
         55 . A method for preparing a targeted therapeutic delivery system comprising gaseous precursor-filled liposomes, the method comprising:
 (a) shaking an aqueous solution, comprising a lipid and a therapeutic compound, in the presence of a gaseous precursor; and   (b) separating the resulting gaseous precursor-filled liposomes for therapeutic use.   
     
     
         56 . A method for preparing a targeted therapeutic delivery system comprising gaseous precursor-filled liposomes, the method comprising:
 (a) shaking an aqueous solution, comprising a lipid, in the presence of a gaseous precursor, at a temperature below the gel to liquid crystalline phase transition temperature of the lipid, to form gaseous precursor-filled liposomes;   (b) adding a therapeutic compound; and   (c) separating the resultant gaseous precursor-filled liposomes for therapeutic use.   
     
     
         57 . A method of making therapeutic containing gaseous precursor-filled liposome microspheres, comprising:
 (a) introducing an aqueous solution comprising a lipid and a therapeutic compound into a vessel;   (b) introducing a gaseous precursor into the vessel;   (c) shaking the aqueous lipid solution in the presence of the gaseous precursor so as to instill at least a portion of the gaseous precursor into the aqueous solution, the shaking being performed with sufficient intensity and duration to produce a gaseous precursor-filled-liposome-containing foam above the aqueous solution; and   (d) extracting at least a portion of the gaseous precursor-filled-liposome containing foam from the vessel.   
     
     
         58 . The method of  claim 57 , further comprising cooling the aqueous solution. 
     
     
         59 . The method of  claim 58 , wherein the cooling of the aqueous solution comprises cooling the aqueous solution below the gel to liquid crystalline phase transition temperature of the lipid in the aqueous solution. 
     
     
         60 . The method of  claim 57 , further comprising pressurizing the vessel. 
     
     
         61 . The method of  claim 57 , further comprising sizing the gaseous precursor-filled liposomes. 
     
     
         62 . The method of  claim 61 , wherein the sizing of the gaseous precursor-filled liposomes comprises controlling the size of the gaseous precursor-filled liposomes extracted from the vessel. 
     
     
         63 . The method of  claim 61 , wherein the size of the gaseous precursor-filled liposomes extracted from the vessel is controlled by extracting the gaseous precursor-filled liposomes through a filter. 
     
     
         64 . The method of  claim 61 , wherein the size of the gaseous precursor-filled liposomes extracted from the vessel is controlled by setting the location within the vessel from which the gaseous precursor-filled liposomes are extracted. 
     
     
         65 . The method of  claim 61 , wherein the size of the gaseous precursor-filled liposomes extracted from the vessel is controlled by adjusting the location within the vessel from which the gaseous precursor-filled liposomes are extracted during the extracting of the gaseous precursor-filled liposomes from the vessel. 
     
     
         66 . The method of  claim 61 , wherein the sizing of the gaseous precursor-filled liposomes comprises extruding the extracted gaseous precursor-filled liposomes through a filter. 
     
     
         67 . The method of  claim 61 , wherein the sizing of the gaseous precursor-filled liposomes comprises controlling the intensity of the shaking. 
     
     
         68 . The method of  claim 57 , further comprising the flowing of the gaseous precursor-filled liposomes extracted from the vessel into a syringe without further processing. 
     
     
         69 . The method of  claim 57 , wherein the shaking of the aqueous solution comprises shaking at a frequency of at least about 60 shaking motions per minute. 
     
     
         70 . The method of  claim 57 , wherein the shaking the aqueous solution comprises vortexing of the aqueous solution. 
     
     
         71 . The method of  claim 57 , wherein the shaking of the aqueous solution comprises the shaking of the vessel. 
     
     
         72 . The method of  claim 57 , wherein the shaking of the aqueous solution comprises shaking the aqueous solution with sufficient intensity to create the gaseous precursor-filled-liposomes-containing foam in less than about 30 minutes. 
     
     
         73 . The method of  claim 57 , wherein the shaking of the aqueous solution comprises controlling the duration of the shaking based on the detection of the gaseous precursor-filled-liposome-containing foam. 
     
     
         74 . The method of  claim 73 , wherein the controlling the duration of the shaking based on the detection of the gaseous precursor-filled-liposome-containing foam comprises shaking until the presence of a pre-determined volume of the foam has been detected. 
     
     
         75 . The method of  claim 57  wherein the method is carried out at the activation temperature of the gaseous precursor. 
     
     
         76 . A method for preparing drug delivery systems comprising:
 (a) placing under negative pressure liposomes having encapsulated therein a drug;   (b) incubating the liposomes under the negative pressure for a time sufficient to remove substantially all water from the liposomes; and   c) instilling gas into the liposomes until ambient pressures are achieved, wherein the gas is provided by a gaseous precursor.   
     
     
         77 . The method of  claim 76 , further comprising allowing the liposomes to cool prior to and during step (a) to a temperature between about −10° C. and about −20° C., allowing the liposomes to warm during step (b) to a temperature between about 10° C. and about 20° C., and allowing the liposomes to warm during step (c) to ambient temperatures. 
     
     
         78 . The method of  claim 76 , wherein the negative pressure is between about 700 mm Hg and about 760 mm Hg and is applied for about 24 to about 72 hours. 
     
     
         79 . The method of  claim 76 , where the gas is instilled into the liposomes over a period of about 4 to about 8 hours. 
     
     
         80 . The method of  claim 76 , where the gas is selected from the group consisting of fluorine, perfluoromethane, perfluoroethane, perfluoropropane, perfluorobutane, perfluoropentane, perfluorohexane, sulfur hexafluoride, hexafluoropropylene, bromochlorofluoromethane, octafluoropropane, 1,1 dichloro, fluoro ethane, hexa fluoroethane, hexafluoro-2-butyne, perfluoropentane, perfluorobutane, octafluoro-2-butene, hexafluorobuta-1,3-diene, octafluorocyclopentene, hexafluoroacetone, isopropyl acetylene, allene, tetrafluoro allene, boron trifluoride, 1,2-butadiene, 1,3-butadiene, 1,2,3-trichloro,2-fluoro-1,3-butadiene, 2-methyl,1,3-butadiene, hexafluoro-1,3-butadiene, butadiene, 1-fluoro-butane, 2-methyl-butane, decafluoro butane, 1-butene, 2-butene, 2-methyl-1-butene, 3-methyl-1-butene, perfluoro-1-butene, perfluoro-2-butene, 4-phenyl-3-butene-2-one, 2-methyl-1-butene-3-yne, butyl nitrate, 1-butyne, 2-butyne, 2-chloro-1,1,1,4,4,4-hexafluoro-butyne, 3-methyl-1-butyne, perfluoro-2-butyne, 2-bromo-butyraldehyde, carbonyl sulfide, crotononitrile, cyclobutane, methyl-cyclobutane, octafluoro-cyclobutane, perfluoro-cyclobutene, 3-chloro-cyclopentene, cyclopropane, 1,2-dimethyl-cyclopropane, 1,1-dimethyl-cyclopropane, 1,2-dimethyl cyclopropane, ethyl cyclopropane, methyl cyclopropane, diacetylene, 3-ethyl-3-methyl diaziridine, 1,1,1-trifluoro-diazoethane, dimethyl amine, hexafluoro-dimethyl amine, dimethylethylamine, bis-(dimethyl phosphine)amine, 2,3-dimethyl-2-norbornane, perfluoro-dimethylamine, dimethyloxonium chloride, 1,3-dioxolane-2-one, 4-methyl, 1,1,1,2-tetrafluoro ethane, 1,1,1 trifluoroethane, 1,1,2,2-tetrafluoroethane, 1,1,2-trichloro-1,2,2-trifluoroethane, 1,1 dichloro ethane, 1,1-dichloro-1,2,2,2-tetrafluoro ethane, 1,2-difluoro ethane, 1-chloro-1,1,2,2,2-pentafluoro ethane, 2-chloro,1,1-difluoroethane, 1-chloro-1,1,2,2-tetrafluoro ethane, 2-chloro,1,1-difluoro ethane, chloroethane, chloropentafluoro ethane, dichlorotrifluoroethane, fluoro-ethane, hexafluoro-ethane, nitro-pentafluoro ethane, nitroso-pentafluoro ethane, perfluoro ethane, perfluoro ethylamine, ethyl vinyl ether, 1,1-dichloro ethylene, 1,1-dichloro-1,2-difluoro ethylene, 1,2-difluoro ethylene, methane, methane-sulfonyl chloride-trifluoro, methane-sulfonyl fluoride-trifluoro, methane-(pentafluorothio)trifluoro, methane-bromo difluoro nitroso, methane-bromo fluoro, methane-bromo chloro-fluoro, methane-bromo-trifluoro, methane-chloro difluoro nitro, methane-chloro dinitro, methane-chloro fluoro, methane-chloro trifluoro, methane-chloro-difluoro, methane-dibromo difluoro, methane-dichloro difluoro, methane-dichloro-fluoro, methane-difluoro, methane-difluoro-iodo, methane-disilano, methane-fluoro, methane-iodo-trifluoro, methane-nitro-trifluoro, methane-nitroso-trifluoro, methane-tetrafluoro, methane-trichlorofluoro, methane-trifluoro, methanesulfenylchloride-trifluoro, 2-methyl butane, methyl ether, methyl isopropyl ether, methyl lactate, methyl nitrite, methyl sulfide, methyl vinyl ether, neon, neopentane, nitrogen, nitrous oxide, 1,2,3-nonadecane tricarboxylic acid-2-hydroxytrimethylester, 1-nonene-3-yne, oxygen, 1,4-pentadiene, n-pentane, pentane-perfluoro, 2-pentanone-4-amino-4-methyl, 1-pentene, 2-pentene{cis}, 2pentene{trans}, 1-pentene-3-bromo, 1-pentene-perfluoro, phthalic acid-tetrachloro, piperidine-2,3,6-trimethyl, propane, propane-1,1,1,2,2,3-hexafluoro, propane-1,2-epoxy, propane-2,2 difluoro, propane-2-amino, propane-2-chloro, propane-heptafluoro-1-nitro, propane-heptafluoro-1-nitroso, propane-perfluoro, propene, propyl-1,1,1,2,3,3-hexafluoro-2,3 dichloro, propylene-1-chloro, propylene-chloro-{trans}, propylene-2-chloro, propylene-3-fluoro, propylene-perfluoro, propyne, propyne-3,3,3-trifluoro, styrene-3-fluoro, sulfur hexafluoride, sulfur(di)-decafluoro(S 2 F 10 ), toluene-2,4-5 diamino, trifluoroacetonitrile, trifluoromethyl peroxide, trifluoromethyl sulfide, tungsten hexafluoride, vinyl acetylene, vinyl ether, and xenon. 
     
     
         81 . The method of  claim 76 , where the gas is 1-fluorobutane. 
     
     
         82 . The method of  claim 76 , further comprising, after step (c), extruding the liposomes through at least one filter of a selected pore size. 
     
     
         83 . A method for preparing drug delivery systems comprising:
 (a) allowing liposomes having encapsulated therein a drug to cool to a temperature between about −10° C. and about −20° C.;   (b) placing the liposomes under a negative pressure of between about 700 mm Hg to about 760 mm Hg;   (c) incubating the liposomes under the negative pressure for about 24 to about 72 hours to remove substantially all water from the liposomes, while allowing the liposomes to warm to a temperature between about 10° C. and about 20° C.; and   (d) instilling gas into the liposomes over a period of about 4 to about 8 hours until ambient pressures are achieved, while allowing the liposomes to warm to ambient temperature, wherein the gas is provided by a gaseous precursor.   
     
     
         84 . The method of  claim 83 , where the gas is selected from the group consisting of fluorine, perfluoromethane, perfluoroethane, perfluoropropane, perfluorobutane, perfluoropentane, perfluorohexane, sulfur hexafluoride, hexafluoropropylene, bromochlorofluoromethane, octafluoropropane, 1,1 dichloro, fluoro ethane, hexa fluoroethane, hexafluoro-2-butyne, perfluoropentane, perfluorobutane, octafluoro-2-butene, hexalluorobuta-1,3-diene, octafluorocyclopentene, hexafluoroacetone, isopropyl acetylene, allene, tetrafluoro allene, boron trifluoride, 1,2-butadiene, 1,3-butadiene, 1,2,3-trichloro,2-fluoro-1,3-butadiene, 2-methyl,1,3-butadiene, hexafluoro-1,3-butadiene, butadiene, 1-fluoro-butane, 2-methyl-butane, decafluorobutane, 1-butene, 2-butene, 2-methyl-1-butene, 3-methyl-1-butene, perfluoro-1-butene, perfluoro-2-butene, 4-phenyl-3-butene-2-one, 2-methyl-1-butene-3-yne, butyl nitrate, 1-butyne, 2-butyne, 2-chloro-1,1,1,4,4,4-hexafluoro-butyne, 3-methyl-1-butyne, perfluoro-2-butyne, 2-bromo-butyraldehyde, carbonyl sulfide, crotononitrile, cyclobutane, methyl-cyclobutane, octafluoro-cyclobutane, perfluoro-cyclobutene, 3-chloro-cyclopentene, cyclopropane, 1,2-dimethyl-cyclopropane, 1,1-dimethyl-cyclopropane, 1,2-dimethyl cyclopropane, ethyl cyclopropane, methyl cyclopropane, diacetylene, 3-ethyl-3-methyl diaziridine, 1,1,1-trifluoro-diazoethane, dimethyl amine, hexafluoro-dimethyl amine, dimethylethylamine, bis-(dimethyl phosphine)amine, 2,3-dimethyl-2-norbornane, perfluoro-dimethylamine, dimethyloxonium chloride, 1,3-dioxolane-2-one, 4-methyl, 1,1,1,2-tetrafluoro ethane, 1,1,1 trifluoroethane, 1,1,2,2-tetrafluoroethane, 1,1,2-trichloro-1,2,2-trifluoroethane, 1,1 dichloro ethane, 1,1-dichloro-1,2,2,2-tetrafluoro ethane, 1,2-difluoro ethane, 1-chloro-1,1,2,2,2-pentafluoro ethane, 2-chloro,1,1-difluoroethane, 1-chloro-1,1,2,2-tetrafluoroethane, 2-chloro,1,1-difluoro ethane, chloroethane, chloropentafluoro ethane, dichlorotrifluoroethane, fluoroethane, hexafluoro-ethane, nitro-pentafluoro ethane, nitroso-pentafluoro ethane, perfluoro ethane, perfluoro ethylamine, ethyl vinyl ether, 1,1-dichloro ethylene, 1,1-dichloro-1,2-difluoro ethylene, 1,2-difluoro ethylene, methane, methane-sulfonyl chloride-trifluoro, methane-sulfonyl fluoride-trifluoro, methane-(pentafluorothio)trifluoro, methane-bromodifluoro nitroso, methane-bromo fluoro, methane-bromo chloro-fluoro, methane-bromo-trifluoro, methane-chloro difluoro nitro, methane-chloro dinitro, methane-chloro fluoro, methane-chloro trifluoro, methane-chloro-difluoro, methane-dibromo difluoro, methane-dichloro difluoro, methane-dichloro-fluoro, methane-difluoro, methane-difluoro-iodo, methane-disilano, methane -fluoro, methane-iodo-trifluoro, methane-nitro-trifluoro, methane-nitroso-trifluoro, methane-tetrafluoro, methane-trichlorofluoro, methane-trifluoro, methanesulfenylchloride-trifluoro, 2-methyl butane, methyl ether, methyl isopropyl ether, methyl lactate, methyl nitrite, methyl sulfide, methyl vinyl ether, neon, neopentane, nitrogen, nitrous oxide, 1,2,3-nonadecane tricarboxylic acid-2-hydroxytrimethylester, 1-nonene-3-yne, oxygen, 1,4-pentadiene, n-pentane, pentane-perfluoro, 2-pentanone-4-amino-4-methyl, 1-pentene, 2-pentene{cis}, 2-pentene{trans}, 1-pentene-3-bromo, 1-pentene-perfluoro, phthalic acid-tetrachloro, piperidine-2,3,6-trimethyl, propane, propane-1,1,1,2,2,3-hexafluoro, propane-1,2-epoxy, propane-2,2 difluoro, propane-2-amino, propane-2-chloro, propane-heptafluoro-1-nitro, propane-heptafluoro-1-nitroso, propane-perfluoro, propene, propyl-1,1,1,2,3,3-hexafluoro-2,3 dichloro, propylene-1-chloro, propylene-chloro-{trans}, propylene-2-chloro, propylene-3-fluoro, propylene-perfluoro, propyne, propyne-3,3,3-trifluoro, styrene-3-fluoro, sulfur hexafluoride, sulfur(di)-decafluoro(S 2 F 10 ), toluene-2,4-diamino, trifluoroacetonitrile, trifluoromethyl peroxide, trifluoromethyl sulfide, tungsten hexafluoride, vinyl acetylene, vinyl ether, and xenon. 
     
     
         85 . The method of  claim 83 , where the gas is 1-fluorobutane. 
     
     
         86 . The method of  claim 83 , further comprising, after step (d), extruding the liposomes through at least one filter of a selected pore size. 
     
     
         87 . A product produced by the method of  claim 76 . 
     
     
         88 . A product produced by the method of  claim 83 . 
     
     
         89 . A drug delivery system prepared by a method comprising:
 (a) placing under negative pressure liposomes having encapsulated therein a drug;   (b) incubating the liposomes under the negative pressure for a time sufficient to remove substantially all water from the liposomes; and   (c) instilling gas into the liposomes until ambient pressures are achieved, wherein the gas is provided by a gaseous precursor.   
     
     
         90 . The method of  claim 89 , wherein the method is carried out at the activation temperature of the gaseous precursor. 
     
     
         91 . A method of imaging ischemic and diseased tissues comprising:
 (a) administering to a target site of a patient a drug delivery system comprising gas-filled microspheres having encapsulated therein a drug, wherein the gas is provided by a gaseous precursor having an activation temperature of about body temperature;   (b) monitoring the microspheres using energy to determine the accumulation of microspheres at the target site and the phase transition of the gaseous precursor from a liquid to a gas and to determine the presence of the microspheres in the region; and   (c) rupturing the microspheres using energy to release the drugs in the region.   
     
     
         92 . A method for preparing a drug delivery system comprising gas-filled liposomes, the method comprising shaking an aqueous solution comprising a lipid and a therapeutic compound, in the presence of a fluorinated gas, at a temperature below the gel to liquid crystalline phase transition temperature of the lipid. 
     
     
         93 . The method of  claim 92 , wherein the fluorinated gas is selected from the group consisting of fluorine gas, 1-fluorobutane, hexafluoro acetone, tetrafluoroallene, boron trifluoride, 1,2,3-trichloro, 2-fluoro-1,3-butadiene, hexafluoro-1,3-butadiene, 1-fluoro-butane, 1,2,3-trichloro, 2-fluoro-1,3-butadiene; hexafluoro-1,3-butadiene; 1-fluoro-butane; decafluoro butane; perfluoro-1-butene; perfluoro-1-butene; perfluoro-2-butene; 2-chloro-1,1,1,4,4,4-hexafluoro-butyne; perfluoro-2-butyne; octafluoro-cyclobutane; perfluoro-cyclobutene; perfluoroethane; perfluoropropane; perfluorobutane; perfluoropentane; perfluorohexane; 1,1,1-trifluorodiazoethane; hexafluoro-dimethyl amine; perfluorodimethylamine; 4-methyl-1,1,1,2-tetrafluoro ethane; 1,1,1-trifluoroethane; 1,1,2,2-tetrafluoroethane; 1,1,2-trichloro-1,2,2-trifluoroethane; 1,1-dichloro-1,2,2,2-tetrafluoro ethane; 1,2-difluoro ethane; 1-chloro-1,1,2,2,2-pentafluoro ethane; 2-chloro, 1,1-difluoroethane; 1-chloro-1,1,2,2-tetrafluoro ethane; 2-chloro,1,1-difluoroethane; chloropentafluoro ethane; dichlorotrifluoroethane; fluoro-ethane; hexafluoro-ethane; nitro-pentafluoro ethane; nitroso-pentafluoro ethane; perfluoro ethane; perfluoro ethylamine; 1,1-dichloro-1,2-difluoro ethylene; 1,2-difluoro ethylene; methane-sulfonyl chloride-trifluoro; methanesulfonyl fluoride-trifluoro; methane-(pentafluoro-thio)trifluoro; methane-bromo difluoro nitroso; methane-bromo fluoro; methane-bromo chloro-fluoro; methanebromo-trifluoro; methane-chloro difluoro nitro; methanechloro fluoro; methane-chloro trifluoro; methane-chloro-difluoro; methane dibromo difluoro; methane-dichloro difluoro; methane-dichloro-fluoro; methanedifluoro; methane-difluoro-iodo; methane-fluoro; methane-iodo-trifluoro; methane-nitro-trifluoro; methane-nitroso-trifluoro; methane-tetrafluoro; methane-trichlorofluoro; methane-trifluoro; methanesulfenylchloride-trifluoro; pentane-perfluoro; 1-pentane-perfluoro; propane-1,1,1,2,2,3-hexafluoro; propane-2,2 difluoro; propane-heptafluoro-1-nitro; propane-heptafluoro-1-nitroso; propane-perfluoro; propyl-1,1,1,2,3,3-hexafluoro-2,3 dichloro; propylene-3-fluoro; propylene-perfluoro; propyne-3,3,3-trifluoro; styrene-3-fluoro; sulfur hexafluoride; sulfur(di)-decafluoro; trifluoroacetonitrile; trifluoromethyl peroxide; trifluoromethyl sulfide; tungsten hexafluoride; pentafluoro octadecyl iodide, perfluorooctylbromide, perfluorodecalin, perfluorododecalin, perfluorooctyliodide; perfluorotripropylamine; perfluorotributylamine; hexafluoropropylene; bromochlorofluoromethane; octafluoropropane, 1,1 dichloro, fluoro ethane; hexafluoroethane; hexafluoro-2-butyne; perfluoropentane; perfluorobutane; octafluoro-2-butene, hexafluorobuta-1,3-diene; and octafluorocyclopentene. 
     
     
         94 . The method of  claim 93 , wherein the fluorinated gas is selected from the group consisting of fluorine gas, perfluoromethane, perfluoroethane, perfluoropropane, perfluorobutane, perfluoropentane, perfluorohexane, sulfur hexafluoride, hexafluoropropylene, octafluoropropane, perfluorocyclobutane, octafluorocyclopentene, dodecafluoropentane, and octafluorocyclobutane. 
     
     
         95 . The method of  claim 93 , wherein the fluorinated gas is selected from the group consisting of perfluoromethane, perfluoroethane, perfluoropropane, perfluorobutane, perfluorocyclobutane, and sulfur hexafluoride. 
     
     
         96 . The method of  claim 95 , wherein the fluorinated gas is selected from the group consisting of perfluoropropane, perfluorocyclobutane, and perfluorobutane. 
     
     
         97 . The method of  claim 92 , wherein the fluorinated gas is perfluoropropane. 
     
     
         98 . The method of  claim 92 , wherein the fluorinated gas is a perfluorocarbon gas. 
     
     
         99 . The method of  claim 98 , wherein the perfluorocarbon gas is selected from the group consisting of perfluoromethane, perfluoroethane, perfluoropropane, perfluorobutane, and perfluorocyclobutane. 
     
     
         100 . The method of  claim 99 , wherein the perfluorocarbon gas is selected from the group consisting of perfluoropropane, perfluorocyclobutane, and perfluorobutane. 
     
     
         101 . The method of  claim 100 , wherein the perfluorocarbon gas is perfluoropropane. 
     
     
         102 . A method for preparing a targeted therapeutic delivery system comprising gas-filled liposomes, the method comprising:
 (a) shaking an aqueous solution comprising a lipid, in the presence of a fluorinated gas, at a temperature below the gel to liquid crystalline phase transition temperature of the lipid, to form gas-filled liposomes; and   (b) adding to the liposomes a therapeutic compound.   
     
     
         103 . The method of  claim 102 , wherein the fluorinated gas is selected from the group consisting of fluorine gas, 1-fluorobutane, hexafluoro acetone, tetrafluoroallene, boron trifluoride, 1,2,3-trichloro, 2-fluoro-1,3-butadiene, hexafluoro-1,3-butadiene, 1-fluoro-butane, 1,2,3-trichloro, 2-fluoro-1,3-butadiene; hexafluoro-1,3-butadiene; 1-fluoro-butane; decafluoro butane; perfluoro-1-butene; perfluoro-1-butene; perfluoro-2-butene; 2-chloro-1,1,1,4,4,4-hexafluoro-butyne; perfluoro-2-butyne; octafluoro-cyclobutane; perfluoro-cyclobutene; perfluoroethane; perfluoropropane; perfluorobutane; perfluoropentane; perfluorohexane; 1,1,1-trifluorodiazoethane; hexafluoro-dimethyl amine; perfluorodimethylamine; 4-methyl,1,1,1,2-tetrafluoro ethane; 1,1,1-trifluoroethane; 1,1,2,2-tetrafluoroethane; 1,1,2-trichloro-1,2,2-trifluoroethane; 1,1-dichloro-1,2,2,2-tetrafluoro ethane; 1,2-difluoro ethane; 1-chloro-1,1,2,2,2-pentafluoro ethane; 2-chloro, 1,1-difluoroethane; 1-chloro-1,1,2,2-tetrafluoro ethane; 2-chloro,1,1-difluoroethane; chloropentafluoro ethane; dichlorotrifluoroethane; fluoro-ethane; hexafluoro-ethane; nitro-pentafluoro ethane; nitroso-pentafluoro ethane; perfluoro ethane; perfluoro ethylamine; 1,1-dichloro-1,2-difluoro ethylene; 1,2-difluoro ethylene; methane-sulfonyl chloride-trifluoro; methanesulfonyl fluoride-trifluoro; methane-(pentafluoro-thio)trifluoro; methane-bromo difluoro nitroso; methane-bromo fluoro; methane-bromo chloro-fluoro; methanebromo-trifluoro; methane-chloro difluoro nitro; methanechloro fluoro; methane-chloro trifluoro; methane-chloro-difluoro; methane dibromo difluoro; methane-dichloro difluoro; methane-dichloro-fluoro; methanedifluoro; methane-difluoro-iodo; methane-fluoro; methane-iodo-trifluoro; methane-nitro-trifluoro; methane-nitroso-trifluoro; methane-tetrafluoro; methane-trichlorofluoro; methane-trifluoro; methanesulfenylchloride-trifluoro; pentane-perfluoro; 1-pentane-perfluoro; propane-1,1,1,2,2 3-hexafluoro; propane-2,2 difluoro; propane-heptafluoro-1-nitro; propane-heptafluoro-1-nitroso; propane-perfluoro; propyl-1,1,1,2,3,3-hexafluoro-2,3 dichloro; propylene-3-fluoro; propylene-perfluoro; propyne-3,3,3-trifluoro; styrene-3-fluoro; sulfur hexafluoride; sulfur(di)-decafluoro; trifluoroacetonitrile; trifluoromethyl peroxide; trifluoromethyl sulfide; tungsten hexafluoride; pentafluoro octadecyl iodide; perfluorooctylbromide; perfluorodecalin; perfluorododecalin; perfluorooctyliodide; perfluorotripropylamine; perfluorotributylamine; hexafluoropropylene; bromochlorofluoromethane; octafluoropropane, 1,1 dichloro, fluoro ethane; hexafluoroethane; hexafluoro-2-butyne; perfluoropentane; perfluorobutane; octafluoro-2-butene; hexafluorobuta-1,3-diene; and octafluorocyclopentene. 
     
     
         104 . The method of  claim 103 , wherein the fluorinated gas is selected from the group consisting of fluorine gas, perfluoromethane, perfluoroethane, perfluoropropane, perfluorobutane, perfluoropentane, perfluorohexane, sulfur hexafluoride, hexafluoropropylene, octafluoropropane, perfluorocyclobutane, octafluorocyclopentene, dodecafluoropentane, and octafluorocyclobutane. 
     
     
         105 . The method of  claim 104 , wherein the fluorinated gas is selected from the group consisting of perfluoromethane, perfluoroethane, perfluoropropane, perfluorobutane, perfluorocyclobutane, and sulfur hexafluoride. 
     
     
         106 . The method of  claim 105 , wherein the fluorinated gas is selected from the group consisting of perfluoropropane, perfluorocyclobutane, and perfluorobutane. 
     
     
         107 . The method of  claim 106 , wherein the fluorinated gas is perfluoropropane. 
     
     
         108 . The method of  claim 102 , wherein the fluorinated gas is a perfluorocarbon gas. 
     
     
         109 . The method of  claim 102 , wherein the perfluorocarbon gas is selected from the group consisting of perfluoromethane, perfluoroethane, perfluoropropane, perfluorobutane, and perfluorocyclobutane. 
     
     
         110 . The method of  claim 109 , wherein the perfluorocarbon gas is selected from the group consisting of perfluoropropane, perfluorocyclobutane, and perfluorobutane. 
     
     
         111 . The method of  claim 110 , wherein the perfluorocarbon gas is perfluoropropane. 
     
     
         112 . A method for preparing a targeted therapeutic delivery system comprising gas-filled liposomes, the method comprising:
 (a) shaking an aqueous solution comprising a lipid and a therapeutic compound, in the presence of a fluorinated gas; and   (b) separating the resulting gas-filled liposomes for therapeutic use.   
     
     
         113 . The method of  claim 112 , wherein the fluorinated gas is selected from the group consisting of fluorine gas, 1-fluorobutane, hexafluoro acetone, tetrafluoroallene, boron trifluoride, 1,2,3-trichloro, 2-fluoro-1,3-butadiene, hexafluoro-1,3-butadiene, 1-fluoro-butane, 1,2,3-trichloro, 2-fluoro-1,3-butadiene; hexafluoro-1,3-butadiene; 1-fluoro-butane; decafluoro butane; perfluoro-1-butene; perfluoro-1-butene; perfluoro-2-butene; 2-chloro-1,1,1,4,4,4-hexafluoro-butyne; perfluoro-2-butyne; octafluoro-cyclobutane; perfluoro-cyclobutene; perfluoroethane; perfluoropropane; perfluorobutane; perfluoropentane; perfluorohexane; 1,1,1-trifluorodiazoethane; hexafluoro-dimethyl amine; perfluorodimethylamine; 4-methyl,1,1,1,2-tetrafluoro ethane; 1,1,1-trifluoroethane; 1,1,2,2-tetrafluoroethane; 1,1,2-trichloro-1,2,2-trifluoroethane; 1,1-dichloro-1,2,2,2-tetrafluoro ethane; 1,2-difluoro ethane; 1-chloro-1,1,2,2,2-pentafluoro ethane; 2-chloro, 1,1-difluoroethane; 1-chloro-1,1,2,2-tetrafluoro ethane; 2-chloro,1,1-difluoroethane; chloropentafluoro ethane; dichlorotrifluoroethane; fluoro-ethane; hexafluoro-ethane; nitro-pentafluoro ethane; nitroso-pentafluoro ethane; perfluoro ethane; perfluoro ethylamine; 1,1-dichloro-1,2-difluoro ethylene; 1,2-difluoro ethylene; methane-sulfonyl chloride-trifluoro; methanesulfonyl fluoride-trifluoro; methane-(pentafluoro-thio)trifluoro; methane-bromo difluoro nitroso; methane-bromo fluoro; methane-bromo chloro-fluoro; methanebromo-trifluoro; methane-chloro difluoro nitro; methanechloro fluoro; methane-chloro trifluoro; methane-chloro-difluoro; methane dibromo difluoro; methane-dichloro difluoro; methane-dichloro-fluoro; methanedifluoro; methane-difluoro-iodo; methane-fluoro; methane-iodo-trifluoro; methane-nitro-trifluoro; methane-nitroso-trifluoro; methane-tetrafluoro; methane-trichlorofluoro; methane-trifluoro; methanesulfenylchloride-trifluoro; pentane-perfluoro; 1-pentane-perfluoro; propane-1,1,1,2,2,3-hexafluoro; propane-2,2 difluoro; propane-heptafluoro-1-nitro; propane-heptafluoro-1-nitroso; propane-perfluoro; propyl-1,1,1,2,3,3-hexafluoro-2,3 dichloro; propylene-3-fluoro; propylene-perfluoro; propyne-3,3,3-trifluoro; styrene-3-fluoro; sulfur hexafluoride; sulfur(di)-decafluoro; trifluoroacetonitrile; trifluoromethyl peroxide; trifluoromethyl sulfide; tungsten hexafluoride; pentafluoro octadecyl iodide; perfluorooctylbromide; perfluorodecalin; perfluorododecalin; perfluorooctyliodide; perfluorotripropylamine; perfluorotributylamine; hexafluoropropylene; bromochlorofluoromethane; octafluoropropane; 1,1 dichloro, fluoro ethane; hexafluoroethane; hexafluoro-2-butyne; perfluoropentane; perfluorobutane; octafluoro-2-butene; hexafluorobuta-1,3-diene; and octafluorocyclopentene. 
     
     
         114 . The method of  claim 113 , wherein the fluorinated gas is selected from the group consisting of fluorine gas, perfluoromethane, perfluoroethane, perfluoropropane, perfluorobutane, perfluoropentane, perfluorohexane, sulfur hexafluoride, hexafluoropropylene, octafluoropropane, perfluorocyclobutane, octafluorocyclopentene, dodecafluoropentane, and octafluorocyclobutane. 
     
     
         115 . The method of  claim 114 , wherein the fluorinated gas is selected from the group consisting of perfluoromethane, perfluoroethane, perfluoropropane, perfluorobutane, perfluorocyclobutane, and sulfur hexafluoride. 
     
     
         116 . The method of  claim 115 , wherein the fluorinated gas is selected from the group consisting of perfluoropropane, perfluorocyclobutane, and perfluorobutane. 
     
     
         117 . The method of  claim 116 , wherein the fluorinated gas is perfluoropropane. 
     
     
         118 . The method of  claim 112 , wherein the fluorinated gas is a perfluorocarbon gas. 
     
     
         119 . The method of  claim 118 , wherein the perfluorocarbon gas is selected from the group consisting of perfluoromethane, perfluoroethane, perfluoropropane, perfluorobutane, and perfluorocyclobutane. 
     
     
         120 . The method of  claim 119 , wherein the perfluorocarbon gas is selected from the group consisting of perfluoropropane, perfluorocyclobutane, and perfluorobutane. 
     
     
         121 . The method of  claim 120 , wherein the perfluorocarbon gas is perfluoropropane. 
     
     
         122 . A method for preparing a targeted therapeutic delivery system comprising gas-filled liposomes, the method comprising:
 (a) shaking an aqueous solution comprising a lipid, in the presence of a fluorinated gas, at a temperature below the gel to liquid crystalline phase transition temperature of the lipid, to form gas-filled liposomes;   (b) adding a therapeutic compound; and   (c) separating the resultant gas-filled liposomes for therapeutic use.   
     
     
         123 . The method of  claim 122 , wherein the fluorinated gas is selected from the group consisting of fluorine gas, 1-fluorobutane, hexafluoro acetone, tetrafluoroallene, boron trifluoride, 1,2,3-trichloro, 2-fluoro-1,3-butadiene, hexafluoro-1,3-butadiene, 1-fluoro-butane, 1,2,3-trichloro, 2-fluoro-1,3-butadiene; hexafluoro-1,3-butadiene; 1-fluoro-butane; decafluoro butane; perfluoro-1-butene; perfluoro-1-butene; perfluoro-2-butene; 2-chloro-1,1,1,4,4,4-hexafluoro-butyne; perfluoro-2-butyne; octafluoro-cyclobutane; perfluoro-cyclobutene; perfluoroethane; perfluoropropane; perfluorobutane; perfluoropentane; perfluorohexane; 1,1,1-trifluorodiazoethane; hexafluoro-dimethyl amine; perfluorodimethylamine; 4-methyl-1,1,1,2-tetrafluoro ethane; 1,1,1-trifluoroethane; 1,1,2,2-tetrafluoroethane; 1,1,2-trichloro-1,2,2-trifluoroethane; 1,1-dichloro-1,2,2,2-tetrafluoro ethane; 1,2-difluoro ethane; 1-chloro-1,1,2,2,2-pentafluoro ethane; 2-chloro, 1,1-difluoroethane; 1-chloro-1,1,2,2-tetrafluoro ethane; 2-chloro, 1,1-difluoroethane; chloropentafluoro ethane; dichlorotrifluoroethane; fluoro-ethane; hexafluoro-ethane; nitro-pentafluoro ethane; nitroso-pentafluoro ethane; perfluoro ethane; perfluoro ethylamine; 1,1-dichloro-1,2-difluoro ethylene; 1,2-difluoro ethylene; methane-sulfonyl chloride-trifluoro; methanesulfonyl fluoride-trifluoro; methane-(pentafluoro-thio)trifluoro; methane-bromo difluoro nitroso; methane-bromo fluoro; methane-bromo chloro-fluoro; methanebromo-trifluoro; methane-chloro difluoro nitro; methanechloro fluoro; methane-chloro trifluoro; methane-chloro-difluoro; methane dibromo difluoro; methane-dichloro difluoro; methane-dichloro-fluoro; methanedifluoro; methane-difluoro-iodo; methane-fluoro; methane-iodo-trifluoro; methane-nitro-trifluoro; methane-nitroso-trifluoro; methane-tetrafluoro; methane-trichlorofluoro; methane-trifluoro; methanesulfenylchloride-trifluoro; pentane-perfluoro; 1-pentane-perfluoro; propane-1,1,1,2,2,3-hexafluoro; propane-2,2 difluoro; propane-heptafluoro-1-nitro; propane-heptafluoro-1-nitroso; propane-perfluoro; propyl-1,1,1,2,3,3-hexafluoro-2,3 dichloro; propylene-3-fluoro; propylene-perfluoro; propyne-3,3,3-trifluoro; styrene-3-fluoro; sulfur hexafluoride; sulfur(di)-decafluoro; trifluoroacetonitrile; trifluoromethyl peroxide; trifluoromethyl sulfide; tungsten hexafluoride; pentafluoro octadecyl iodide; perfluorooctylbromide; perfluorodecalin; perfluorododecalin; perfluorooctyliodide; perfluorotripropylamine; perfluorotributylamine; hexafluoropropylene; bromochlorofluoromethane; octafluoropropane; 1,1 dichloro, fluoro ethane; hexa fluoroethane; hexafluoro-2-butyne; perfluoropentane; perfluorobutane; octafluoro-2-butene; hexafluorobuta-1,3-diene; and octafluorocyclopentene. 
     
     
         124 . The method of  claim 123 , wherein the fluorinated gas is selected from the group consisting of fluorine gas, perfluoromethane, perfluoroethane, perfluoropropane, perfluorobutane, perfluoropentane, perfluorohexane, sulfur hexafluoride, hexafluoropropylene, octafluoropropane, perfluorocyclobutane, octafluorocyclopentene, dodecafluoropentane, and octafluorocyclobutane. 
     
     
         125 . The method of  claim 124 , wherein the fluorinated gas is selected from the group consisting of perfluoromethane, perfluoroethane, perfluoropropane, perfluorobutane, perfluorocyclobutane, and sulfur hexafluoride. 
     
     
         126 . The method of  claim 125 , wherein the fluorinated gas is selected from the group consisting of perfluoropropane, perfluorocyclobutane, and perfluorobutane. 
     
     
         127 . The method of  claim 126 , wherein the fluorinated gas is perfluoropropane. 
     
     
         128 . The method of  claim 122 , wherein the fluorinated gas is a perfluorocarbon gas. 
     
     
         129 . The method of  claim 128 , wherein the perfluorocarbon gas is selected from the group consisting of perfluoromethane, perfluoroethane, perfluoropropane, perfluorobutane, and perfluorocyclobutane. 
     
     
         130 . The method of  claim 129 , wherein the perfluorocarbon gas is selected from the group consisting of perfluoropropane, perfluorocyclobutane, and perfluorobutane. 
     
     
         131 . The method of  claim 130 , wherein the perfluorocarbon gas is perfluoropropane.

Join the waitlist — get patent alerts

Track US2010254904A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.